ISDA’s amicus program is another important way that we fulfill our commitment to advocacy on behalf of the industry. ISDA files amicus briefs, known as “friend of the court” briefs, in court cases around the world that raise important policy issues that impact the over the counter derivatives market and market participants.
Because of ISDA’s role in the development of derivatives markets, ISDA is uniquely well positioned to address issues of general importance to the industry. For example, ISDA has filed numerous briefs addressing the interpretation of the safe harbor provisions in the Bankruptcy Code as well as defending ISDA documentation provisions.
ISDA’s amicus program continues to actively monitor litigations that may impact the OTC derivatives market or market participants and we welcome member suggestions for possible participation in cases.
Latest
Collateral Puts Focus on Cross-product Netting
More collateral than ever before is being held to cover cleared and non-cleared derivatives exposures. This is an important risk mitigant and helps to make financial markets more resilient, but that collateral needs to come from somewhere. As the volume...
ISDA AGM 2026: Day 1 Scott O’Malia Opening Remarks
ISDA Annual General Meeting Boston, USA April 29, 2026 Opening Remarks: Financial Markets Revolution Scott O’Malia, ISDA CEO “These are the times that try men’s souls.” Those were the words of Thomas Paine, written in 1776 to boost morale...
ISDA Animation: Using AI to Enhance ISDA's DRR
ISDA’s Digital Regulatory Reporting (DRR) solution has already helped firms automate regulatory reporting requirements by applying a single, golden-source interpretation of reporting rules and converting them into code using the Common Domain Model (CDM). ISDA’s new animation explains how artificial...
ISDA Margin Survey Year-end 2025
ISDA has published its latest annual margin survey, which shows that initial margin (IM) and variation margin (VM) collected by the leading derivatives market participants for their non-cleared derivatives exposures increased by 9.3% to a record $1.6 trillion at the...